Qian Hu

Peucedanum praeruptorum Dunn

Also known as: Peucedanum root(English) 前胡(Chinese)

Zenko前胡 ゼンコ(JP also admits Angelica decursiva root (ChP lists that separately as 紫花前胡)) Jeonho前胡 전호 Tiền hồ(source gives Peucedanum spp.) Ch'ien Hu

Updated October 29, 2026 · Not yet clinically reviewed

Qian Hu
Photo: 阿橋 HQ, CC BY-SA 2.0, via Wikimedia Commons

Safety at a glance

Caution

4 recorded drug interactions, 1 major or contraindicated

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, breastfeeding, incompatible pairs (十八反 / 十九畏), herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
transforming phlegm
Temperature
Cool
Taste
Bitter,Pungent
Channels
Lung

Functions

Descends Qi and Transforms Phlegm; Disperses Wind-Heat; Resolves Phlegm and Stops Cough

Traditional uses

Qian Hu (hogfennel root) is a cool, bitter, pungent herb with a dual action on the Lungs: it redirects rebellious Lung Qi downward to stop cough and wheezing, while also transforming Phlegm-Heat. It is appropriate for coughs accompanied by yellow, thick sputum and chest tightness, as well as for early stages of Wind-Heat invasion where these Lung symptoms are present. It pairs well with other Phlegm-clearing and Wind-Heat-dispersing herbs.

Western herbalism

Properties: expectorant, antispasmodic

Pharmacological effects

  • Expectorant: Decoction 1 g/kg orally increased respiratory secretion in anesthetized cats; no significant antitussive effect against iodine-induced cough.
  • Antispasmodic: Ether-soluble fraction of P. praeruptorium relaxed guinea pig ileum and taenia coli contracted by acetylcholine and histamine; praeruptorin A antagonized acetylcholine noncompetitively.
  • Inhibition of platelet aggregation: In vitro, nodakenin and nodakenetin most strongly inhibited ADP-induced human platelet aggregation; decurosides III and IV were the most active decurosides.
  • Antiviral: 1:1 decoction inhibited Asian influenza virus type A in chick embryos.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 486.

Formulas using this herb

18 of 18 formulas

Botanical

Peucedanum praeruptorum is a perennial herb in the Apiaceae family, native to central and southern China, where it grows on grassy mountain slopes and at the edges of forests. The plant grows 60-100 cm tall from a stout, cylindrical, somewhat conical taproot 4-15 cm long with a knobby crown bearing the remains of leaf bases. The stem is erect, finely ridged, and branched in the upper portion. The basal and lower stem leaves are large, triangular-ovate in outline, and two-to-three times ternately or pinnately compound, with serrate, ovate to lanceolate leaflets. Small white flowers are borne in compound umbels 4-8 cm across in summer, followed by ovoid, slightly winged schizocarp fruits. In TCM, the dried root (Qian Hu) is used as a bitter, acrid, slightly cold herb that disperses wind-heat, descends qi, and resolves phlegm in cough disorders.

Family
Apiaceae
Pharmaceutical name
Radix Peucedani
Parts used
root
Plant type
herb
Native region
Anhui, Hunan, Jiangxi, Sichuan, Zhejiang

Constituents

Praeruptorin A

Angular pyranocoumarin (khellactone diester) · The most abundant bioactive metabolite of the root; the marker compound on which Chinese Pharmacopoeia assay of Qian Hu rests

An orally active calcium channel blocker that produces vasodilatation and lowers blood pressure in animals. It is also a CYP3A4 substrate and is cleared rapidly by human liver microsomes through oxidation, hydrolysis, intramolecular acyl migration and glucuronidation, implying extensive hepatic first-pass elimination. Both properties matter clinically: the first for additive hypotension, the second for interaction risk.

Praeruptorin B

Angular pyranocoumarin (khellactone diester) · Second most abundant pyranocoumarin of the root after praeruptorin A

Co-occurs with praeruptorin A and shares its khellactone core. In a comparative pharmacological evaluation against whole-drug extracts it accounted, with praeruptorin A, for much of the observed activity of the crude drug. Metabolised in human and rat liver microsomes, so it contributes to the same CYP3A4 competition as praeruptorin A.

Praeruptorin C

Angular pyranocoumarin (khellactone diester) · Minor pyranocoumarin of the root; not routinely assayed

Significantly increases CYP3A4 mRNA, protein and catalytic activity through activation of the pregnane X receptor in cell models. This is an inducing rather than inhibiting action and is the mechanistic basis for expecting reduced exposure to co-prescribed CYP3A4 substrates on repeated dosing.

Praeruptorin D

Angular pyranocoumarin (khellactone diester) · Minor pyranocoumarin of the root; not routinely assayed

Up-regulates CYP3A expression via the pregnane X receptor, shown for both human CYP3A4 and rodent Cyp3a11. The authors framed the work explicitly as a prediction of herb-drug interactions between Qian Hu and co-administered CYP3A4 substrates.

Imperatorin

Linear furanocoumarin · Reported at 0.000 to 1.188 mg/g across germplasm and producing regions, the widest range of any furanocoumarin in the root

The most abundant of the root's linear furanocoumarins, and the one whose content varies most between sources. Furanocoumarins of this class are photosensitising under ultraviolet irradiation and are the structural family responsible for grapefruit-type mechanism-based inhibition of CYP3A4, which pulls in the opposite direction to the pregnane X receptor induction produced by the praeruptorins.

Bergapten (5-methoxypsoralen)

Linear furanocoumarin · Reported at 0.000 to 0.471 mg/g in Peucedanum praeruptorum root

A recognised photosensitiser used clinically in psoralen plus ultraviolet A therapy. Its presence, even at low milligram-per-gram levels, is the reason Qian Hu should not be assumed free of phototoxic potential in patients receiving phototherapy or other photosensitising drugs.

Psoralen

Linear furanocoumarin · Reported at 0.000 to 0.058 mg/g, the lowest of the three linear furanocoumarins measured

The most phototoxic of the linear furanocoumarins on a weight basis, ranked above bergapten, peucedanin and xanthotoxin in comparative phototoxicity testing, but present here at the lowest concentration of the three. Relevant to risk assessment rather than to therapeutic effect.

Oxypeucedanin

Angular-type furanocoumarin · Reported at 0.002 to 0.340 mg/g in Peucedanum praeruptorum root

Present at low and relatively consistent levels. Included because furanocoumarin content is the part of the Qian Hu profile most often overlooked when the drug is described simply as a pyranocoumarin herb.

Drug interactions

CYP3A4 substrates with a narrow therapeutic index (ciclosporin, tacrolimus, midazolam, simvastatin, direct oral anticoagulants)

Major · Loss of efficacy or toxicity depending on direction and duration of exposure · Evidence level: Probable

Qian Hu acts on CYP3A4 in both directions and the net effect depends on timing. Praeruptorins C and D each up-regulate CYP3A4 messenger RNA, protein and activity through pregnane X receptor activation, which on repeated dosing lowers exposure to co-administered substrates. Against that, praeruptorin A is itself a CYP3A4 substrate cleared rapidly by human liver microsomes, so acute competition for the enzyme is expected, and the root also carries the linear furanocoumarins imperatorin, bergapten and psoralen, the structural class responsible for mechanism-based CYP3A4 inhibition in grapefruit juice. The evidence is cell-based and microsomal; no human interaction study has been published, and the magnitude in patients is unknown.

Clinical note: Avoid Qian Hu in transplant patients on calcineurin inhibitors and in anyone on a CYP3A4-cleared narrow-therapeutic-index drug unless levels can be monitored. Where the herb is nonetheless used, check drug levels or clinical endpoints after roughly two weeks, and again after stopping, since induction reverses over several days.

Calcium channel blockers and other antihypertensives

Moderate · Additive hypotension · Evidence level: Possible

Praeruptorin A, the principal constituent of the root, is characterised pharmacologically as a calcium channel blocker that mediates vasodilatation, inhibits vascular hypertrophy and reduces blood pressure in animal models of renovascular and spontaneous hypertension. Adding a herb whose main constituent shares the mechanism of a dihydropyridine is a plausible route to additive blood-pressure lowering, though no human study has measured it and dose-response in people has never been established.

Clinical note: Check blood pressure and ask about dizziness or postural symptoms in patients already on a calcium channel blocker. Not a contraindication at ordinary decoction doses, but a reason to review rather than to add blindly.

Photosensitising drugs and ultraviolet phototherapy (amiodarone, tetracyclines, thiazides, PUVA)

Moderate · Phototoxic skin reaction · Evidence level: Possible

The root contains the linear furanocoumarins psoralen, bergapten and imperatorin, which are photosensitising, phototoxic, mutagenic and photocarcinogenic under irradiation, with phototoxic potency ranking psoralen above bergapten above peucedanin above xanthotoxin. Concentrations in Qian Hu are low, in the range of hundredths to about one milligram per gram, and no phototoxic reaction has been reported from the drug in clinical use, so this is a mechanism-based caution rather than a documented event.

Clinical note: Ask about phototherapy and photosensitising medication, and advise sun protection during courses in patients on such drugs. Do not co-prescribe during an active PUVA course.

Zi Hua Qian Hu (Angelica decursiva, formerly Peucedanum decursivum) supplied as Qian Hu

Moderate · Delivery of a chemically different drug under the same pinyin name · Evidence level: Established

Angelica decursiva root was listed as a co-source of Qian Hu in Chinese Pharmacopoeia editions from 1963 to 2000 and was separated out from the 2005 edition, since when only Peucedanum praeruptorum may be dispensed as Qian Hu. The two are chemically distinct: P. praeruptorum is defined by angular pyranocoumarins (praeruptorins A and B), whereas A. decursiva contains mainly linear dihydropyranocoumarins and linear dihydrofuranocoumarins. Because market demand outstrips supply and the roots look similar, P. praeruptorum is also adulterated by a wider set of regional substitutes; DNA barcoding of the nuclear ribosomal internal transcribed spacer region has been used to separate the genuine drug from 13 substitutes and 23 adulterants, and hand-held near-infrared spectroscopy with partial least squares discriminant analysis reached 93.4 percent accuracy against adulterants.

Clinical note: Buy Qian Hu only from suppliers who can state the binomial and, ideally, provide identity testing. A pale root with a whitish cross-section and indistinct radial markings should prompt a query. Substituted A. decursiva will not deliver the praeruptorin content the prescription assumes.

Dosage

FormAmountFrequencyNotes
decoction3–10 gDaily
中国药典 2020 【用法与用量】3~10g。 【性味与归经】苦、辛,微寒。归肺经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Dui yao: classical pairings

Qian Hu + Bai Qian白前

One disperses wind-heat and descends qi, the other descends qi and dispels phlegm; together they stop cough with copious phlegm whether or not an exterior pattern remains.

Named pairing — Lü Jingshan, Shi Jinmo Dui Yao

Evidence

Study design on record, not certainty of outcome.

Systematic review / meta-analysis
1
In vitro / animal
4

Biological Activities and Pharmacokinetics of Praeruptorins from Peucedanum Species: A Systematic Review

Sarkhail P, Shafiee A, Sarkheil P · BioMed Research International · 2013 · systematic review

Systematic review / meta-analysis · Verified

Systematic review of the praeruptorin literature across Peucedanum species covering pharmacology and pharmacokinetics. Its central caution is that despite long traditional use, clinical trials establishing dose-response, efficacy and safety in humans are lacking, which remains the accurate summary of Qian Hu's evidence base.

doi:10.1155/2013/343808

Up-regulatation of CYP3A expression through pregnent X receptor by praeruptorin D isolated from Peucedanum praeruptorum Dunn

Huang L, Huang M, Li YH, Li RM, Zeng Y, Kuang SY, Zhang L, Wang YT, Bi HC · Journal of Ethnopharmacology · 2013 · in vitro

In vitro / animal · Not yet verified

Praeruptorin D activated the pregnane X receptor and up-regulated CYP3A4 in human cell models and Cyp3a11 in rodent systems. The authors state the purpose explicitly as predicting herb-drug interactions between praeruptorin D, Qianhu and co-administered CYP3A4 substrates. Cell and animal level; the title is registered with the two typographical errors shown and is reproduced as published. An erratum appeared in the same journal in 2014; the article has not been retracted or subjected to an expression of concern.

doi:10.1016/j.jep.2013.05.008

PXR-Mediated Upregulation of CYP3A Expression by Herb Compound Praeruptorin C from Peucedanum praeruptorum Dunn

Huang L, Wu Q, Li YH, Wang YT, Bi HC · Evidence-Based Complementary and Alternative Medicine · 2013 · in vitro

In vitro / animal · Not yet verified

Praeruptorin C significantly increased CYP3A4 messenger RNA, protein expression and functional activity through a pregnane X receptor mediated pathway. Confirms that the induction signal in this herb is not carried by a single coumarin. An erratum was published in the same journal in 2014; the article has not been retracted or subjected to an expression of concern.

doi:10.1155/2013/156574

Identification of cytochrome P450 isoenzymes involved in metabolism of (+)-praeruptorin A, a calcium channel blocker, by human liver microsomes using ultra high-performance liquid chromatography coupled with tandem mass spectrometry

Jing WH, Song YL, Yan R, Wang YT · Journal of Pharmaceutical and Biomedical Analysis · 2013 · in vitro

In vitro / animal · Not yet verified

Human liver microsome study identifying the cytochrome P450 isoenzymes that metabolise praeruptorin A and confirming CYP3A4 as a route of clearance. Praeruptorin A was metabolised rapidly, indicating extensive hepatic first-pass elimination, with oxidation, hydrolysis, intramolecular acyl migration and glucuronidation as the main routes. Human tissue but not human dosing.

doi:10.1016/j.jpba.2013.01.023

Isolation of praeruptorins A and B from Peucedanum praeruptorum Dunn. and their general pharmacological evaluation in comparison with extracts of the drug

Lu M, Nicoletti M, Battinelli L, Mazzanti G · Il Farmaco · 2001 · animal

In vitro / animal · Verified

Compared isolated praeruptorins A and B with whole extracts of the root in a general pharmacological screen, tying the activity of the crude drug to its two principal pyranocoumarins. Useful because it tests the isolated compounds against the drug as dispensed rather than only in isolation.

doi:10.1016/s0014-827x(01)01053-9

Safety

Contraindications

Its use is cautious in patients with cough due to yin deficiency or cold fluid-retention.

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 267–277.

Cultural and historical

Ming Yi Bie Lu · Six Dynasties, c. 500 CE, attributed to Tao Hongjing

The first materia medica to record Qian Hu. Its indications are the ones still used: treating phlegm fullness, glomus in the chest and rib-side, bound qi in the heart and abdomen, wind headache, removing phlegm accumulation and descending qi, and treating cold damage with alternating chills and fever.

Ben Cao Gang Mu (Li Shizhen) · Ming dynasty, 1596

Condenses the drug's action to clearing Lung heat, transforming phlegm-heat and dispersing wind evil, which is the formulation that survives in modern textbooks as descending qi and transforming phlegm while dispersing wind-heat.

Zhi Wu Ming Shi Tu Kao (Wu Qijun) · Qing dynasty, 1848

Its illustration of Qian Hu is detailed enough to be identified confidently as the white-flowered species, Peucedanum praeruptorum, rather than the purple-flowered Angelica decursiva. This is the textual anchor for treating Bai Hua Qian Hu as the authentic drug.

Pharmacopoeia of the People's Republic of China · Modern regulatory, 1963 to 2000 editions and 2005 edition onward

Editions from 1963 to 2000 admitted both Peucedanum praeruptorum and Angelica decursiva as sources of Qian Hu. From the 2005 edition only Peucedanum praeruptorum may be dispensed under that name, with Angelica decursiva separated as Zi Hua Qian Hu. Any pre-2005 source describing Qian Hu may therefore be describing either species.

References

  1. Wang Q, Sun Q, Huang Q, Qin L, Zhu B. The traditional uses, pharmacology, and phytochemistry of Peucedanum praeruptorum Dunn. Frontiers in Pharmacology. 2024 doi:10.3389/fphar.2024.1352657
  2. Chen R, Wang W, Chen C, Xu Z, Pu J, Xu P. Quality formation in Peucedanum praeruptorum dunn: metabolite biosynthesis, geoherbal variation, and early bolting regulation. Frontiers in Plant Science. 2026 doi:10.3389/fpls.2026.1812786
  3. Liu Z, Zhou J, Wang W, Liu M. Molecular authentication of the traditional medicinal plant Peucedanum praeruptorum and its substitutes and adulterants by dna 0 - barcoding technique. Pharmacognosy Magazine. 2014 doi:10.4103/0973-1296.141754
  4. Wang F, Jia B, Song X, Dai J, Li X, Gao H, Pan H, Yan H, Han B. Rapid Identification of Peucedanum praeruptorum Dunn and Its Adulterants by Hand-Held Near-Infrared Spectroscopy. Journal of AOAC INTERNATIONAL. 2021 doi:10.1093/jaoacint/qsab160
  5. Kim JH, Doh EJ, Lee G. Chemotaxonomic Classification of Peucedanum japonicum and Its Chemical Correlation with Peucedanum praeruptorum, Angelica decursiva, and Saposhnikovia divaricata by Liquid Chromatography Combined with Chemometrics. Molecules. 2022 doi:10.3390/molecules27051675
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice